The report focuses on the Prostate Cancer Diagnostics market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Prostate Cancer Diagnostics market.
Major Players in the Prostate Cancer Diagnostics market are:
OPKO Health, Inc
Siemens Healthcare GmbH
Myriad Genetics, Inc.
Minomic
Diagnolita
Exosome Diagnostics
MDx Health
Myriad Genetics
Gregor Diagnostics
F. Hoffman-La Roche AG
Genomic Health
Abbott Laboratories
Caldera Health
On the basis of types, the Prostate Cancer Diagnostics market is primarily split into:
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 test
Others
On the basis of applications, the market covers:
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Prostate Cancer Diagnostics Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Prostate Cancer Diagnostics Market Overview
1.1 Product Overview and Scope of Prostate Cancer Diagnostics Market
1.2 Prostate Cancer Diagnostics Market Segment by Type
1.2.1 Global Prostate Cancer Diagnostics Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Prostate Cancer Diagnostics Market Segment by Application
1.3.1 Prostate Cancer Diagnostics Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Prostate Cancer Diagnostics Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Prostate Cancer Diagnostics (2017-2029)
1.5.1 Global Prostate Cancer Diagnostics Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Prostate Cancer Diagnostics Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Prostate Cancer Diagnostics Industry
1.7 Impact of Carbon Neutrality on the Prostate Cancer Diagnostics Industry
2 Prostate Cancer Diagnostics Market Upstream and Downstream Analysis
2.1 Prostate Cancer Diagnostics Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Prostate Cancer Diagnostics Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 OPKO Health, Inc
3.1.1 OPKO Health, Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Siemens Healthcare GmbH
3.2.1 Siemens Healthcare GmbH Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Myriad Genetics, Inc.
3.3.1 Myriad Genetics, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Minomic
3.4.1 Minomic Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Diagnolita
3.5.1 Diagnolita Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Exosome Diagnostics
3.6.1 Exosome Diagnostics Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.6.4 Business Overview
3.7 MDx Health
3.7.1 MDx Health Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Myriad Genetics
3.8.1 Myriad Genetics Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Gregor Diagnostics
3.9.1 Gregor Diagnostics Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.9.4 Business Overview
3.10 F. Hoffman-La Roche AG
3.10.1 F. Hoffman-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Genomic Health
3.11.1 Genomic Health Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Abbott Laboratories
3.12.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Caldera Health
3.13.1 Caldera Health Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Prostate Cancer Diagnostics Market Performance (2017-2022)
3.13.4 Business Overview
4 Global Prostate Cancer Diagnostics Market Landscape by Player
4.1 Global Prostate Cancer Diagnostics Sales and Share by Player (2017-2022)
4.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Player (2017-2022)
4.3 Global Prostate Cancer Diagnostics Average Price by Player (2017-2022)
4.4 Global Prostate Cancer Diagnostics Gross Margin by Player (2017-2022)
4.5 Prostate Cancer Diagnostics Market Competitive Situation and Trends
4.5.1 Prostate Cancer Diagnostics Market Concentration Rate
4.5.2 Prostate Cancer Diagnostics Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Prostate Cancer Diagnostics Sales, Revenue, Price Trend by Type
5.1 Global Prostate Cancer Diagnostics Sales and Market Share by Type (2017-2022)
5.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2017-2022)
5.3 Global Prostate Cancer Diagnostics Price by Type (2017-2022)
5.4 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate of PSA Tests (2017-2022)
5.4.2 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate of CTC Tests (2017-2022)
5.4.3 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate of Immunohistochemistry (2017-2022)
5.4.4 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate of PCA3 test (2017-2022)
5.4.5 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate of Others (2017-2022)
6 Global Prostate Cancer Diagnostics Market Analysis by Application
6.1 Global Prostate Cancer Diagnostics Consumption and Market Share by Application (2017-2022)
6.2 Global Prostate Cancer Diagnostics Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Prostate Cancer Diagnostics Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Prostate Cancer Diagnostics Consumption and Growth Rate of Hospital Associated Labs (2017-2022)
6.3.2 Global Prostate Cancer Diagnostics Consumption and Growth Rate of Independent Diagnostic Laboratories (2017-2022)
6.3.3 Global Prostate Cancer Diagnostics Consumption and Growth Rate of Cancer Research Institutes (2017-2022)
6.3.4 Global Prostate Cancer Diagnostics Consumption and Growth Rate of Others (2017-2022)
7 Global Prostate Cancer Diagnostics Sales and Revenue Region Wise (2017-2022)
7.1 Global Prostate Cancer Diagnostics Sales and Market Share, Region Wise (2017-2022)
7.2 Global Prostate Cancer Diagnostics Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Prostate Cancer Diagnostics Market Forecast (2022-2029)
8.1 Global Prostate Cancer Diagnostics Sales, Revenue Forecast (2022-2029)
8.1.1 Global Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Prostate Cancer Diagnostics Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Prostate Cancer Diagnostics Price and Trend Forecast (2022-2029)
8.2 Global Prostate Cancer Diagnostics Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Prostate Cancer Diagnostics Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Prostate Cancer Diagnostics Sales and Revenue Forecast (2022-2029)
8.2.3 China Prostate Cancer Diagnostics Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Prostate Cancer Diagnostics Sales and Revenue Forecast (2022-2029)
8.2.5 India Prostate Cancer Diagnostics Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Prostate Cancer Diagnostics Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Prostate Cancer Diagnostics Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Prostate Cancer Diagnostics Sales and Revenue Forecast (2022-2029)
8.3 Global Prostate Cancer Diagnostics Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Prostate Cancer Diagnostics Revenue and Growth Rate of PSA Tests (2022-2029)
8.3.2 Global Prostate Cancer Diagnostics Revenue and Growth Rate of CTC Tests (2022-2029)
8.3.3 Global Prostate Cancer Diagnostics Revenue and Growth Rate of Immunohistochemistry (2022-2029)
8.3.4 Global Prostate Cancer Diagnostics Revenue and Growth Rate of PCA3 test (2022-2029)
8.3.5 Global Prostate Cancer Diagnostics Revenue and Growth Rate of Others (2022-2029)
8.4 Global Prostate Cancer Diagnostics Consumption Forecast by Application (2022-2029)
8.4.1 Global Prostate Cancer Diagnostics Consumption Value and Growth Rate of Hospital Associated Labs (2022-2029)
8.4.2 Global Prostate Cancer Diagnostics Consumption Value and Growth Rate of Independent Diagnostic Laboratories (2022-2029)
8.4.3 Global Prostate Cancer Diagnostics Consumption Value and Growth Rate of Cancer Research Institutes (2022-2029)
8.4.4 Global Prostate Cancer Diagnostics Consumption Value and Growth Rate of Others (2022-2029)
8.5 Prostate Cancer Diagnostics Market Forecast Under COVID-19
9 Industry Outlook
9.1 Prostate Cancer Diagnostics Market Drivers Analysis
9.2 Prostate Cancer Diagnostics Market Restraints and Challenges
9.3 Prostate Cancer Diagnostics Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Prostate Cancer Diagnostics Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Prostate Cancer Diagnostics Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Prostate Cancer Diagnostics Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global HPV Testing Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 21-Mar-2023 Price: US 3260 Onwards Pages: 102
The HPV Testing market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the HPV Testing industry, and breaks down according to the type, application, and consumption area of HPV Testing. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......
2023 World Tumor Marker Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--A 92-Country Analysis--Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Published: 16-Mar-2023 Price: US 28500 Onwards Pages: 0
This new 92-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget.
This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective b......
2023 Asia-Pacific Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--An 18-Country Analysis--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Published: 16-Mar-2023 Price: US 14500 Onwards Pages: 0
The report is available in Local PDF, Global PDF, and Data Pack formats (supplier shares, test volumes, sales forecasts). The report is delivered in both Excel and PDF.This new 18-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget.
This report is designed to assist diagnostics industry executives, as well as c......
2023 Europe Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--A 38-Country Analysis--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Published: 16-Mar-2023 Price: US 19500 Onwards Pages: 0
This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget.
This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business......
2023 Latin America Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--A 22-Country Analysis--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Published: 16-Mar-2023 Price: US 14500 Onwards Pages: 0
The report is available in Local PDF, Global PDF, and Data Pack formats (supplier shares, test volumes, sales forecasts). The report is delivered in both Excel and PDF.This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget.
This report is designed to assist diagnostics industry executives, as well as ......
2023 Middle East Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--An 11-Country Analysis--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Published: 16-Mar-2023 Price: US 8500 Onwards Pages: 0
This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget.
This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business......
2023 North America Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--US, Canada, Mexico--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Published: 16-Mar-2023 Price: US 8500 Onwards Pages: 0
This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget.
This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business s......
2023 Global Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--US, Europe, Japan--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Published: 16-Mar-2023 Price: US 19500 Onwards Pages: 0
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years.The report is available by section, and can be customized to specific information needs and budget.The report examines trends in the U.S., Europe and Japan; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market se......
2023 Europe Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--France, Germany, Italy, Spain, UK--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Published: 16-Mar-2023 Price: US 14500 Onwards Pages: 0
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years.The report is available by section, and can be customized to specific information needs and budget.The report examines trends in major European countries; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market se......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
